Recombinant Microbial Pathway for 1,4-Butanediol Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for biosynthesizing 1,4-butanediol from xylose are inefficient, involving numerous steps and resulting in low yields due to the highly reduced nature of 1,4-butanediol relative to carbohydrates, making it difficult to develop effective pathways and organisms for direct production from renewable sources.
Innovation Solution
A novel shortcut metabolic pathway is engineered in microbial cells, specifically in E. coli, to convert xylose into 1,4-butanediol in just six steps, utilizing enzymes such as xylose dehydrogenase, xylonolactonase, and 2-keto-3-deoxyaldonic acid dehydratase, with plasmids expressing decarboxylase and alcohol dehydrogenase to enhance production efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional biosynthetic pathways are used to convert xylose to 1,4-butanediol, then the process can proceed through standard metabolic routes, but the number of steps increases and yield decreases
Solution Approach 1:
The biosynthetic pathway is divided into distinct modular segments: xylose uptake, oxidation to xylonate, conversion to 2-keto-3-deoxyxylonate, and final reduction to 1,4-butanediol. Each segment is catalyzed by specific heterologous enzymes that can be independently optimized and regulated, allowing for streamlined metabolism and improved yield while maintaining pathway manageability.
Solution Approach 2:
The pathway is designed to perform preliminary oxidation of xylose to xylonate and further to 2-keto-3-deoxyxylonate before the final reduction step. This preliminary action prepares the substrate in a form that is more amenable to efficient conversion to 1,4-butanediol, bypassing intermediate steps that would otherwise be required in conventional pathways.
2Device complexity
If the highly reduced nature of 1,4-butanediol is addressed by using direct reduction pathways, then fewer steps are required, but it becomes difficult to develop effective pathways and organisms for direct production
Solution Approach 1:
The pathway uses 2-keto-3-deoxyxylonate as an intermediary compound that bridges the gap between xylose oxidation products and 1,4-butanediol. This intermediary is naturally produced by heterologous enzymes and serves as an ideal substrate for the final reduction step, facilitating direct production while maintaining biochemical feasibility and ease of manufacture.
Solution Approach 2:
The pathway alters key metabolic parameters by introducing heterologous enzymes with optimized catalytic properties. The enzymes are selected and engineered to operate under industrial fermentation conditions, with optimized kinetics and specificity that enable efficient conversion through the reduced pathway, making direct production both effective and manufacturable.
3Productivity
If conventional pathways are used, then standard metabolic routes are followed, but by-product formation increases and efficiency decreases
Solution Approach 1:
The pathway extracts and utilizes specific heterologous enzymes that catalyze only the necessary reactions for 1,4-butanediol production from xylose. By taking out only the essential catalytic steps and removing redundant or alternative metabolic routes, the pathway minimizes by-product formation and maximizes efficiency, as each enzyme is dedicated to a specific transformation in the streamlined pathway.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the yield of 1,4-butanediol, producing 1.0 g/L from 20 g/L xylose with minimal by-products, outperforming conventional pathways by reducing the number of steps and by-product formation, thus achieving higher yields and efficiency.
Implementation Method 1
utilizing enzymes such as xylose dehydrogenase, xylonolactonase, and 2-keto-3-deoxyaldonic acid dehydratase
Implementation Method 2
xylose dehydrogenase activity
Implementation Method 3
xylonolactonase activity
Implementation Method 4
xylonate dehydratase activity, or 2-keto-3-deoxyaldonic acid dehydratase activity
Data Source
AI summary
This disclosure describes a recombinant microbial cells and methods of making and using such recombinant microbial cells. Generally, the recombinant cells may be modified to exhibit increased biosynthesis of a TCA derivative compared to a wild-type control. In some embodiments, the TCA derivative can include 1,4-butanediol. In various embodiments, the microbial cell is a fungal cell or a bacterial cell. In some embodiments, the increased biosynthesis of the TCA derivative can include an increase in xylose dehydrogenase activity, xylonolactonase activity, xylonate dehydratase activity, or 2-keto-3-deoxyaldonic acid dehydratase activity.